-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group’s Bosheng Medical Devices Wins the Third Prize for Scientific and Technological Progress from the China Council for the Promotion of International Trade in 2024.
Category:
发布时间：2025-01-09
【概要描述】
Recently, the results of the 2024 China Council for the Promotion of International Trade Science and Technology Awards were announced. The project “Key Technologies and Industrialization of Multi-Layer Co-Extruded Single-Use Biomedical Membranes for Medical Systems,” jointly submitted by Shijiazhuang Sihua Pharmaceutical Group’s Jiangsu Bosheng Medical New Materials Co., Ltd. and Jiangsu University of Science and Technology, was awarded the Third Prize for Scientific and Technological Progress.
Recently, the results of the 2024 China Council for the Promotion of International Trade Science and Technology Awards were announced. The project “Key Technologies and Industrialization of Multilayer Co-extruded Single-use Biomedical Membranes for Medical Systems,” jointly submitted by Shijiazhuang Sihua Pharmaceutical Group’s Jiangsu Bosheng Medical New Materials Co., Ltd. and Jiangsu University of Science and Technology, was awarded the Third Prize for Scientific and Technological Progress.
Over the past two years, the Group’s Boshi Biomedical Materials division has remained at the forefront of the market, adhering to a new-product development strategy centered on “expanding product variety, upgrading technological capabilities, and enhancing quality and efficiency.” To this end, it has strengthened industry–university–research–application collaboration, further deepened the integrated mechanisms for industry–education and science–education synergy, and focused on conducting fundamental, innovative, and forward-looking research in areas such as rubber stoppers, co-extruded films, and cutting-edge medical packaging materials. The division has actively advanced new-product R&D and technological upgrades, resulting in a significant enhancement of its capacity for technological self-reliance and strength and a steady stream of innovative achievements.
“In research on the key technologies for multi-layer co-extruded single-use biomembrane systems, we have continuously optimized process flows and material formulations through molecular design and reactive blending modification, successfully achieving performance levels in domestically produced biomembrane products that match or surpass those of imported counterparts. This has provided reliable technical support and membrane-material assurance for the large-scale application of single-use reactor systems,” said the project leader. As a key new product launched over the past two years, the biomembrane has so far been granted three invention patents, received the “Top Ten Invention Products of Taizhou City” award and the Third Prize for Quality Technology from the China Association for Quality, been included in the list of “Key Science and Technology Support Projects of Taizhou City,” and been recognized by the Jiangsu Provincial Department of Industry and Information Technology as a “New Product and New Technology of Jiangsu Province.” The product is now widely used by numerous biopharmaceutical companies and has delivered excellent application results.
“Going forward, Bosheng Medical Materials will continue to accelerate technological advancement and develop biofilms into the company’s flagship product,” said the company’s head. The multi-layer co-extruded biomedical film production workshop has achieved cross-departmental business collaboration and integrated control through the integration of an MES system with an industrial-chain collaboration platform, earning it recognition as a Jiangsu Province Smart Manufacturing Workshop. As a result, production efficiency, product quality, and safety have all been significantly enhanced, laying a solid foundation for expanding the company’s product portfolio.
According to available information, the China Council for the Promotion of International Trade Science and Technology Award is an authoritative prize established with the approval of the Ministry of Science and Technology and the Office of National Science and Technology Awards, designed to recognize individuals and organizations that have made outstanding contributions to scientific research, technological innovation, the dissemination of research outcomes, and the industrialization of high and new technologies within the national commerce sector.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091